Last week The Hydropothecary Corporation (TSX-V:THCX) announced that it is moving from the TSX Venture Exchange (TSX-V) to the TSX, with trading commencing on June 22. In celebration of the moment, the company rang the opening bell on Friday. A trend in the cannabis industry, Hydropothecary is just one of many marijuana companies to either go public or uplist in recent months.
The Hydropothecary Corporation is an authorized producer and distributor of medical cannabis in Canada and licensed by Health Canada under the country’s Access to Cannabis for Medical Purposes Regulations. They are the only licensed producer in Quebec.
Happy To Showcase Their Quality
Co-founder and CEO Sebastien St-Louis was clearly gleeful about the move to TSX, explaining in a statement that “graduating to a major exchange such as the TSX demonstrates our growth and proven ability to execute.” St-Louis went on to say that Hydropothecary is happy to showcase their quality and consistency of products on the TSX.
With the move to TSX comes a symbol change to “HEXO”, which was announced previously as the company branded its new product for the adult-use cannabis market, which was legalized across Canada earlier in the week. The common shares and warrants will trade under the symbols “HEXO” and “HEXO.WT” respectively. The company will continue to sell its medical cannabis product line